Endo Posts Disappointing Data From Frozen Shoulder Trial
Endo International plc (NASDAQ:ENDP) has announced topline results from its Phase 2 study of collagenase clostridium histolyticum (CCH) in participants with…
NRx Pharmaceuticals Announces FDA Declines Emergency Use Authorization For ZYESAMI For Subgroup Of Patients With Critical COVID-19 At Immediate Risk Of Death From Respiratory Failure Despite Treatment With Approved Therapy, Including Remdesivir
Focus is now on NRX-101 for Bipolar Depression with Suicidality
RADNOR, Pa., July 1, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), ("NRx Pharmaceuticals"), a clinical-stage
Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca’s COVID-19 Vaccine
Oxford Biomedica plc (OTC:OXBDF) signed a new three-year agreement to potentially make AstraZeneca Plc’s (NASDAQ:AZN) COVID-19 vaccine beyond 2022. The new agreement represents…
Teleflex Highlights Data Supporting Safety And efficacy On UroLift System
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the results of several research studies that further support the safety and efficacy of the
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.